GSK plc
Search results
Jun 17, 2024 · Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better. Explore Career Opportunities.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which
Singapore. We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We Are Sanofi. We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.
In 2004, Aventis merged with and into Sanofi. The new Sanofi-Aventis Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the vaccine division of Sanofi-Aventis Group, changed its name to Sanofi Pasteur.
Global pharmaceutical and healthcare company Sanofi's specialty care & general medicines focus areas.
Jun 3, 2024 · Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
Apr 20, 2022 · Sanofi, together with 15 other top biopharma companies, is part of the BMAC. So too government agencies such as EDB and JTC. Besides collaborating on emerging trends and new opportunities, the BMAC also works together on two important areas – innovation and talent.
Jun 2, 2024 · Sanofi is seeking new approvals for Dupixent to treat chronic obstructive pulmonary disease, a lung condition associated with smoking.
Sanofi broke ground on its Evolutive Vaccine Facility (EVF) in Singapore today, in the presence of Singapore’s Deputy Prime Minister and Coordinating Minister for Economic Policies, Heng Swee Keat, and Sanofi’s Executive Vice President, Head of Vaccines, Thomas Triomphe.
